Diphenhydramine toxicity label warning for oral, topical products proposed by FDA.
This article was originally published in The Tan Sheet
Executive Summary
DIPHENHYDRAMINE TOXICITY LABEL WARNING PROPOSED BY FDA that would advise consumers not to use topical products containing the ingredient on chicken pox, poison ivy, sunburn, large areas of the body, blistered or oozing skin, more often than directed or with any other diphenhydramine-containing product, including those taken orally. FDA published the notice of proposed rulemaking in the Aug. 29 Federal Register. Written comments on the proposal are due by Nov. 28. A final rule would go into effect one year after publication.